Equatorial Guinea vs Rwanda: Average cost of tuberculosis treatment by type
Equatorial Guinea
20 constant 2022 US$
in 2023
Rwanda
20 constant 2022 US$
in 2024
Equatorial Guinea rank
26th
Rwanda rank
26th
Average cost of tuberculosis treatment by type over time
- Equatorial Guinea
- Rwanda
How they compare
Equatorial Guinea currently reports 20 constant 2022 US$ against 20 constant 2022 US$ in Rwanda, a difference of 0 constant 2022 US$.
The two have swapped places 2 times across 5 shared years of data; in 2019 it was Equatorial Guinea ahead.
Equatorial Guinea ranks 26th and Rwanda ranks 26th of 62 countries.
Equatorial Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20 constant 2022 US$ | 13 constant 2022 US$ | 7 constant 2022 US$ | Equatorial Guinea |
| 2020s | 19.5 constant 2022 US$ | 16.75 constant 2022 US$ | 2.75 constant 2022 US$ | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment by type, Equatorial Guinea or Rwanda?
- Equatorial Guinea, at 20 constant 2022 US$ against 20 constant 2022 US$ in Rwanda as of 2023.
- What is the difference in average cost of tuberculosis treatment by type between Equatorial Guinea and Rwanda?
- 0 constant 2022 US$, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Rwanda?
- 5 years are reported by both, from 2019 to 2023.
- How do Equatorial Guinea and Rwanda rank globally for average cost of tuberculosis treatment by type?
- Equatorial Guinea ranks 26th and Rwanda ranks 26th of 62 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of tuberculosis treatment by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per person starting tuberculosis preventive treatment, excluding buffer stock.